TrialLancet (London, England)2025

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial.

Graham S Cooke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.